Abstract
Contactin-associated protein-like 2 (CASPR2) and leucine-rich glioma-inactivated 1 (LGI1) are essential components of the voltage-gated Kv1 potassium channel complex and are extensively expressed in both central and peripheral nervous system. Autoimmune CASPR2 and LGI1 disorders commonly present with Morvan syndrome (Mos) and/or limbic encephalitis, but whether Guillain–Barré syndrome (GBS) is a specific clinical phenotype is unknown. Here, we first reported an adult patient with dual CASPR2 and LGI1 antibodies in both serum and cerebrospinal fluid, who initially presented with a GBS-like syndrome and developed a typical MoS and respiratory paralysis, with a rapid resolution of his neurological symptoms and disappearance of autoantibodies after treatment with plasma exchange. Additionally, we also provided an overview of the previously reported GBS cases associated with CASPR2 or LGI1 antibodies. These cases expand the phenotypic spectrum of CASPR2 and LGI1 autoimmune syndromes, implying that these two antigens, especially CASPR2, are likely to participate in the etiology of GBS as a potential new target antigen, which deserves further exploration.
Similar content being viewed by others
Data availability
The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133(9):2734–2748
Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72(2):241–255
Liguori R, Vincent A, Clover L et al (2001) Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124(Pt 12):2417–2426
Boyko M, Au KLK, Casault C, de Robles P, Pfeffer G (2020) Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol 267(4):1137–1146
Fehmi J, Scherer SS, Willison HJ, Rinaldi S (2018) Nodes, paranodes and neuropathies. J Neurol Neurosurg Psychiatry 89(1):61–71
Devaux JJ, Odaka M, Yuki N (2012) Nodal proteins are target antigens in Guillain–Barre syndrome. J Peripher Nerv Syst 17(1):62–71
Rosch RE, Bamford A, Hacohen Y et al (2014) Guillain–Barre syndrome associated with CASPR2 antibodies: two paediatric cases. J Peripher Nerv Syst 19(3):246–249
Tuzun E, Kinay D, Hacohen Y, Aysal F, Vincent A (2013) Guillain–Barre-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies. Muscle Nerve 48(5):836–837
Lang B, Makuch M, Moloney T et al (2017) Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry 88(4):353–361
Tuzun E, Kurtuncu M, Lang B et al (2010) Bickerstaff’s encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. Eur J Neurol 17(10):1304–1307
Traka M, Goutebroze L, Denisenko N et al (2003) Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 162(6):1161–1172
Poliak S, Salomon D, Elhanany H et al (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162(6):1149–1160
van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13(5):290–301
van Sonderen A, Arino H, Petit-Pedrol M et al (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87(5):521–528
Dalakas MC (2013) Pathophysiology of autoimmune polyneuropathies. Presse Med 42(6 Pt 2):e181-192
Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ (2017) Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy. Muscle Nerve 55(4):520–525
Sagane K, Ishihama Y, Sugimoto H (2008) LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11. Int J Biol Sci 4(6):387–396
Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP (2009) Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 15(10):1208–1214
Lotan I, Djaldetti R, Hellman MA, Benninger F (2016) Atypical case of Morvan’s syndrome. J Clin Neurosci 25:132–134
Gadoth A, Pittock SJ, Dubey D et al (2017) Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol 82(1):79–92
Huijbers MG, Querol LA, Niks EH et al (2015) The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 22(8):1151–1161
Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2014) Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 82(10):879–886
Koneczny I (2020) Update on IgG4-mediated autoimmune diseases: new insights and new family members. Autoimmun Rev 19(10):102646
Lunemann JD, Nimmerjahn F, Dalakas MC (2015) Intravenous immunoglobulin in neurology—mode of action and clinical efficacy. Nat Rev Neurol 11(2):80–89
Jiang Y, Tan C, Li T et al (2022) Phenotypic spectrum of CASPR2 and LGI1 antibodies associated neurological disorders in children. Front Pediatr 10:815976
Jia Y, Shi H, Ye J, Wang Y (2020) Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies. Clin Neurol Neurosurg 197:106187
Kilic MA, Yoruk Yildirim ZN, Oner A et al (2021) Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome. J Neurol 268(12):4492–4494
Lancaster E, Huijbers MG, Bar V et al (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69(2):303–311
Maldonado-Slootjes S, Smetcoren C, Pieret F, Gille M (2021) An unusual association of chronic inflammatory demyelinating polyneuropathy and anti-contactin-associated protein 2 (CASPR2) syndrome. Rev Neurol (Paris) 177(4):431–433
Funding
No funding source has been used.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical standards
This study was approved by the local Institutional Review Board and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from the patient.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tan, X., Liu, Y., Wu, X. et al. Guillain–Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity. J Neurol 269, 5893–5900 (2022). https://doi.org/10.1007/s00415-022-11248-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-022-11248-y